Baross-Francis A, Andrew S E, Penney J E, Jirik F R
Center for Molecular Medicine and Therapeutics, and Department of Medicine, University of British Columbia, Vancouver, BC Canada V5Z 4H4.
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8739-43. doi: 10.1073/pnas.95.15.8739.
DNA mismatch repair (MMR) deficiency is associated with an increased mutational burden and predisposition to certain malignancies. Relatively little is known, however, about gene-specific mutation frequencies within MMR-deficient primary tumors. Thymic lymphomas from Msh2(-/-) mice were thus analyzed by using a lacI-based transgenic shuttle-phage mutation detection system. All tumors exhibited greatly elevated lacI gene mutation frequencies, ranging from 3.2- to 17.4-fold above the approximately 15-fold elevations present within normal Msh2(-/-) thymi. In addition, lacI genes harboring multiple changes, including clusters of mutations, were found in thymic tumor DNA. The results suggest that an additional mutator activity, such as an error-prone DNA polymerase, leads to increased genomic instability in these MMR-deficient tumors.
DNA错配修复(MMR)缺陷与突变负担增加以及某些恶性肿瘤的易感性相关。然而,关于MMR缺陷原发性肿瘤内基因特异性突变频率,人们了解相对较少。因此,通过使用基于lacI的转基因穿梭噬菌体突变检测系统,对Msh2(-/-)小鼠的胸腺淋巴瘤进行了分析。所有肿瘤均表现出lacI基因突变频率大幅升高,比正常Msh2(-/-)胸腺中约15倍的升高幅度还要高3.2至17.4倍。此外,在胸腺肿瘤DNA中发现了携带多种变化(包括突变簇)的lacI基因。结果表明,一种额外的诱变活性,如易出错的DNA聚合酶,导致这些MMR缺陷肿瘤中的基因组不稳定性增加。